Session Title: The Impact of anti-VEGF Injection in the Treatment of Retinopathy of Prematurity
Chairperson(s): S. Agarwal-Sinha USA
Speakers and presentations:
S. Agarwal-Sinha USA
13:00 Introduction
S. Kusaka JAPAN
13:02 The new ICROP3 classification: how it will impact the clinical care with the use of anti-VEGF’s
W. Wu TAIWAN
13:09 Aflibercept for the treatment of type-1 ROP: Rates and Risk Factors for Recurrence of Retinopathy of Prematurity after Laser OR Intravitreal Anti-VEGF Monotherapy
S. Agarwal-Sinha USA
13:16 Role of Imaging and the peripheral avascular retina post anti-VEGF in ROP infants- To Laser or not!!
S. Iyer USA
13:23 Anti-VEGF’s-a future to behold in the management of ROP
H. Kondo JAPAN
13:30 Discussion
13:45 End of Session
